Predictors of patient response to treatment with EGF receptor inhibitors

Details for Australian Patent Application No. 2009246398 (hide)

Owner Bristol-Myers Squibb Company Genomic Health Inc.

Inventors Ford, Shirin K.; Mauro, David J.; Baker, Joffre B.; Watson, Drew; Shak, Steven; Maddala, Tara

Agent FB Rice

Pub. Number AU-A-2009246398

PCT Pub. Number WO2009/140409

Priority 61/127,816 14.05.08 US

Filing date 13 May 2009

Wipo publication date 19 November 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140409 Priority application(s): WO2009/140409

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246402-Pyrrolopyridines as kinase inhibitors

2009246397-Metal abstraction peptide (MAP) tag and associated methods